Author(s)

Chenyu Li , Yunli Wang, Qi An

Corresponding Author

Yunli Wang

Abstract

Objective: to explore the interaction between research & development (be abbreviated to R&D below text) innovation and export trade level in China's pharmaceutical manufacturing industry. Methods :select 10 pharmaceutical enterprises in China's pharmaceutical manufacturing industry, and use super-efficiency DEA model to measure R & D efficiency as the representative index of R & D innovation. The VECM-based Granger causality test method is further adopted to explore the interaction between R & D innovation and export trade level. Results: when the research lag period is 2-4 years, there is a mutual relationship between R & D innovation and export trade level in China's pharmaceutical manufacturing industry, and the change of export trade level of enterprises in the short term is restricted by the long-term equilibrium relationship of R & D innovation. Conclusion: in the process of development, Chinese pharmaceutical manufacturing enterprises should not only pay attention to the development of export trade, but also cannot relax the improvement of R & D innovation level of enterprises, and continue to cycle development to achieve the relative balance of their common progress.

Keywords

Pharmaceutical Manufacturing Industry; Research & Development Innovation; Export Trade; Super-efficiency DEA Model; VECM Model